"Cleveland Clinic is one of the largest and most respected hospitals in the country. Our mission is to provide better care of the sick, investigation into their problems, and further education of those who serve. Learn more about our leadership, vision, values and model of healthcare. Every life deserves world class care. Call or visit our website for appointment information."

During the past decade, Fairview Hospital; Cleveland Clinic Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fairview Hospital; Cleveland Clinic Cancer Center" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Fairview Hospital; Cleveland Clinic Cancer Center" are "Breast Cancer" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Fairview Hospital; Cleveland Clinic Cancer Center" in a lesser frequency.

Most popular intervention types in "Fairview Hospital; Cleveland Clinic Cancer Center" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Atezolizumab Placebo" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Giredestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fairview Hospital; Cleveland Clinic Cancer Center" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fairview Hospital; Cleveland Clinic Cancer Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fairview Hospital; Cleveland Clinic Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fairview Hospital; Cleveland Clinic Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".